Epidemiology of glomerular disease in southern Arizona review of 10-year renal biopsy data

Medicine (United States)

Volumn 95, Issue 18, 2016, Pages e3633-

  Murugapandian, Sangeetha ^a   Mansour, Iyad ^a   Hudeeb, Mohammad ^a   Hamed, Khaled ^a   Hammode, Emad ^a   Bijin, Babitha ^a   Daheshpour, Sepehr ^a   Thajudeen, Bijin ^a   Kadambi, Pradeep ^a  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARIZONA; CONTROLLED STUDY; FEMALE; FOCAL GLOMERULOSCLEROSIS; GLOMERULOPATHY; HISPANIC; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE COMPLEX NEPHRITIS; IMMUNOGLOBULIN A NEPHROPATHY; INCIDENCE; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; MEMBRANO PROLIFERATIVE GLOMERULONEPHRITIS; MEMBRANOUS GLOMERULONEPHRITIS; PATHOGENESIS; PAUCI IMMUNE GLOMERULONEPHRITIS; PREVALENCE; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVIEW; SEX RATIO; YOUNG ADULT; AFRICAN AMERICAN; AGED; AMERICAN INDIAN; BIOPSY; CAUCASIAN; ETHNOLOGY; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; KIDNEY; LUPUS NEPHRITIS; MIDDLE AGED; NEPHROSIS, LIPOID; PATHOLOGY; SEX DIFFERENCE; STATISTICS AND NUMERICAL DATA;

ADULT; AFRICAN AMERICANS; AGED; ARIZONA; BIOPSY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLOMERULONEPHRITIS; GLOMERULONEPHRITIS, IGA; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; GLOMERULONEPHRITIS, MEMBRANOUS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HISPANIC AMERICANS; HUMANS; INDIANS, NORTH AMERICAN; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; NEPHROSIS, LIPOID; SEX FACTORS;

EID: 84969779616     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000003633     Document Type: Review

References (24)

1. Braun N, Schweisfurth A, Lohöfener C, et al. Epidemiology of glomerulonephritis in Northern Germany. Int Urol Nephrol. 2011;43:1117-1126.
2. Swaminathan S, Leung N, Lager DJ III et al. Changing incidence of glomerular disease in Olmsted County, Minnesota: a 30-year renal biopsy study. Clin J Am Soc Nephrol. 2006;1:483-487.
3. Feldman CH, Hiraki LT, Liu J, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013;65:753-763.
4. Richman IB, Taylor KE, Chung SA, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum. 2012;64:3374-3382.
5. Burgos PI, McGwin G Jr, Pons-Estel GJ, et al. US patients of Hispanic and African ancestry develop lupus nephritis early in the disease course: data from LUMINA, a multiethnic US cohort (LUMINA LXXIV). Ann Rheum Dis. 2011;70:393-394.
6. Atisha-Fregoso Y, Jakez-Ocampo J, Llorente L. Systemic lupus erythematosus in Hispanics. Autoimmunity. 2011;44:555-561.
7. Hoy WE, Megill DM, Hughson MD. Epidemic renal disease of unknown etiology in the Zuni Indians. Am J Kidney Dis. 1987;9:485-496.
8. Narva AS. Kidney disease in Native Americans. J Natl Med Assoc. 2002;94:738-742.
9. Smith SM, Tung KS. Incidence of IgA-related nephritides in American Indians in New Mexico. Hum Pathol. 1985;16:181-184.
10. Beals J, Spicer P, Mitchell CM, et al. AI-SUPERPFP Team. Racial disparities in alcohol use: comparison of 2 American Indian reservation populations with national data. Am J Public Health. 2003;93:1683-1685.
11. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-748.
12. Moriyama T, Tanaka K, Iwasaki C, et al. Prognosis in IgA nephropathy: 30-year analysis of 1,012 patients at a single center in Japan. PLoS One. 2014;9:e91756.
13. Li PK, Ho KK, Szeto CC, et al. Prognostic indicators of IgA nephropathy in the Chinese: clinical and pathological perspectives. Nephrol Dial Transplant. 2002;17:64-69.
14. Geetha D, Poulton CJ, Hu Y, et al. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum. 2014;43:778-783.
15. Jayne D, Rasmussen N, Andrassy K, et al. A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med. 2003;349: 36-44.
16. De Groot K, Rasmussen N, Bacon PA, et al. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum. 2005;52:2461-2469.
17. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med. 2002;347:738-748
18. Murphy G, Isenberg D. Effect of gender on clinical presentation in systemic lupus erythematosus. Rheumatology (Oxford) 2013;52(12):2108-2015].
19. Tan TC, Fang H, Magder LS, et al. Differences between male and female systemic lupus erythematosus in a multiethnic population. J Rheumatol. 2012;39:759-769.
20. Lora CM, Daviglus ML, Kusek JW, et al. Chronic kidney disease in United States Hispanics: a growing public health problem. Ethn Dis. 2009;19:466-472.
21. Fiehn C, Hajjar Y, Mueller K, et al. Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment. Ann Rheum Dis. 2003;62:435-439.
22. Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res (Hoboken). 2012;64:797-808.
23. Jennette JC. Rapidly progressive crescentic glomerulonephritis. Kidney Int. 2003;63:1164-1177.
24. Xin G, Zhao MH, Wang HY. Detection rate and antigenic specificities of antineutrophil cytoplasmic antibodies in Chinese patients with clinically suspected vasculitis. Clin Diagn Lab Immunol. 2004;11:559-562.